Actions and Detail Panel

Sales Ended

Date and time


Online event

SARS CoV2 Workshop held by The National Institute of Biological Standards and Control (NIBSC).

About this event

Registration has now closed.

This workshop will provide a forum for molecular diagnostic laboratories, regulators, manufacturers and other stakeholders to discuss the challenges faced during the COVID-19 pandemic. With the rapid development of assays, we look at the challenges faced with detection and quantification of SARS-CoV-2 using new molecular techniques and understand the assurances needed for rolling out these assays to settings beyond the professional diagnostic laboratory.

We will discuss how external quality assurance scheme material has kept pace to provide an international snap shot of events and describe the reference materials now available to support better measurement of the analytical performance of these assays.

Programme and timings

Day 1 - Thursday 10 June 12:00-16:00 (BST)

12:00 Welcome and introduction - Neil Almond, SoGAT Chair

Session 1: 12:00-13:45 - Understanding the challenges

Chair: Bert Niesters

12:05 Evolution of SARS CoV molecular detection

Maria Zambon, PHE, UK

12:25 The Abbott Global Surveillance Program: SARS-CoV-2 variant vigilance

Mary Rodgers Abbott, USA

12:45 Validation of SARS-CoV-2 molecular assays - the WHO 'Emergency Use Listing' experience

Ute Ströher, WHO, Switzerland

13:05 Evaluation of NAT and Ag testing devices

Wayne Dimech, NRL, Australia

13:25 Evaluation of SARS-CoV-2 IVD in the EU

Micha Nübling, PEI, Germany

13:45 Break

Session 2: 14:00-16:00 - Developing reference materials

Chair: Roberta Madej

14:00 Molecular detection of SARS-CoV-2 EQA- Can Ct values be used as an indicator of the viral load?

Sanjiv Rughooputh, NEQAS, UK

14:20 Molecular INSTAND EQA schemes for SARS-CoV-2 detection and a study with National Reference Materials for linking Ct values with SARS-CoV-2 RNA loads”.

Heinz Zeichhardt/Martin Kammel, INSTAND, Germany

14:40 External Quality Assessment (EQA) for SARS-CoV-2 Molecular Detection – Experiences from 2020

Oliver Donoso, QCMD, UK

14:55 Round table discussion session

Chairs: NIBSC

Lessons learned – future pandemics, how can we do things better

How can EQA data be used to improve assays?

15:55 Close

Day 2 - Friday 11 June 12:00-16:00 (BST)

12:00 Welcome and introduction - Neil Almond, SoGAT Chair

Session 3: 12:00-14:00 - dPCR and NGS methods to detect covid19

Chair: Neil Berry

12:05 The CCQM Nucleic Acid Working Group (NAWG) and its response to SARS-CoV-2

Jim Huggett, Chair of the NAWG

12:20 Strategy of the whole genome SARS-CoV-2 Certified Reference Material from the National Measurement Institute, Australia

Daniel Burke, NMIA, Australia

12:35 Digital PCR Measurements of SARS-CoV-2: Lessons Learned (So Far…)

Peter Vallone, NIST, USA

12:50 The impact of targeting different regions of the SARS-CoV-2 genome on the measured quantity

Denise O’Sullivan, NML at LGC, UK

13:05 Using NGS to identify SARS CoV2 variants

Dr Charles Chiu, University of California.

13:25 Round table discussion session 3 - Chairs: NIBSC

  • How can we best use NGS data to understand viral evolution?
  • How can qPCR and dPCR work together?

14:00 Break

Session 4: 14:15-16:00 - Development of reference materials

Chair: Micha Nübling

14:15 Overview of challenges faced when developing reference materials for SARS CoV2


14:30 Development of a WHO SARS CoV2 NAT International Standard

Giada Mattiuzzo, NIBSC, UK

14:50 SARS CoV2 Antigen detection, not all controls are suitable

Jacqueline Fryer, NIBSC, UK

15:10 Calibration of secondary SARS CoV2 reference material

John Sninsky, USA

15:30 Round table discussion session 4 - Chairs: NIBSC

  • What other reference materials are needed?
  • Challenges of clinical relevance vs analytic sensitivity

16:00 Close

Please note programme and timings are subject to change.

Frequently Asked Questions

When will I receive details of how to join the meeting?

Joining instructions with the meeting link will be issued at least 48 hours ahead of the meeting.

Get in touch:

If you have any further questions and/or comments please do get in touch by sending an email to:

Access requirements:

If you have any access requirements that we may address to make your participation at our events more enjoyable, please do let us know when registering.

Data Protection

The Medicines and Healthcare products Regulatory Agency will use the information you have provided via the third-party data processor Eventbrite, to facilitate the event, provide you with an acceptable level of service. Any access requirements will be processed internally and will not be shared in any identifiable way with the venue. We will contact you using the information provided for the purpose of this event. By providing the information you agree to the data being processed and stored as outlined.

Privacy Notices

The National Institute for Biological Standards and Control (NIBSC) has its own privacy notice which outlines how we collect and use personal data in accordance with the Data Protection Act 2018 and the General Data Protection Regulation (GDPR) 2016/679.

To find out how we use and manage your personal data please visit the NIBSC Privacy Notice.

Mailing List

To hear about future Medicines and Healthcare products Regulatory Agency events, please click here to be redirected to the Agency's website where you can subscribe to receive event alerts.

Save This Event

Event Saved